Du Z - Search Results

1

Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer.

Brown BP, Zhang YK, Kim S, Finneran P, Yan Y, Du Z, Kim J, Hartzler AL, LeNoue-Newton ML, Smith AW, Meiler J, Lovly CM. Brown BP, et al. Among authors: du z. Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2206588119. doi: 10.1073/pnas.2206588119. Epub 2022 Jul 22. Proc Natl Acad Sci U S A. 2022. PMID: 35867821 Free PMC article.

2

Mechanisms of receptor tyrosine kinase activation in cancer.

Du Z, Lovly CM. Du Z, et al. Mol Cancer. 2018 Feb 19;17(1):58. doi: 10.1186/s12943-018-0782-4. Mol Cancer. 2018. PMID: 29455648 Free PMC article. Review.

3

On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation.

Brown BP, Zhang YK, Westover D, Yan Y, Qiao H, Huang V, Du Z, Smith JA, Ross JS, Miller VA, Ali S, Bazhenova L, Schrock AB, Meiler J, Lovly CM. Brown BP, et al. Among authors: du z. Clin Cancer Res. 2019 Jun 1;25(11):3341-3351. doi: 10.1158/1078-0432.CCR-18-3829. Epub 2019 Feb 22. Clin Cancer Res. 2019. PMID: 30796031 Free PMC article.

4

Structure-function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting.

Du Z, Brown BP, Kim S, Ferguson D, Pavlick DC, Jayakumaran G, Benayed R, Gallant JN, Zhang YK, Yan Y, Red-Brewer M, Ali SM, Schrock AB, Zehir A, Ladanyi M, Smith AW, Meiler J, Lovly CM. Du Z, et al. Nat Commun. 2021 Mar 2;12(1):1382. doi: 10.1038/s41467-021-21613-6. Nat Commun. 2021. PMID: 33654076 Free PMC article.

5

Structure-Guided Strategies of Targeted Therapies for Patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Du Z, Sun J, Zhang Y, Hesilaiti N, Xia Q, Cui H, Fan N, Xu X. Du Z, et al. Biomolecules. 2023 Jan 20;13(2):210. doi: 10.3390/biom13020210. Biomolecules. 2023. PMID: 36830579 Free PMC article. Review.

6

Residual network improves the prediction accuracy of genomic selection.

Wu H, Gao B, Zhang R, Huang Z, Yin Z, Hu X, Yang CX, Du ZQ. Wu H, et al. Among authors: du zq. Anim Genet. 2024 May 15. doi: 10.1111/age.13445. Online ahead of print. Anim Genet. 2024. PMID: 38746973

7

Association of histone modification with the development of schizophrenia.

Chen YZ, Zhu XM, Lv P, Hou XK, Pan Y, Li A, Du Z, Xuan JF, Guo X, Xing JX, Liu K, Yao J. Chen YZ, et al. Among authors: du z. Biomed Pharmacother. 2024 May 13;175:116747. doi: 10.1016/j.biopha.2024.116747. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38744217 Review.

8

Graph Regulation Network for Point Cloud Segmentation.

Du Z, Liang J, Liang J, Yao K, Cao F. Du Z, et al. IEEE Trans Pattern Anal Mach Intell. 2024 May 13;PP. doi: 10.1109/TPAMI.2024.3400402. Online ahead of print. IEEE Trans Pattern Anal Mach Intell. 2024. PMID: 38739517

9

Exploring the prognostic significance of iron death‑related lncRNAs in colorectal cancer: A systematic review and meta‑analysis.

Hang X, Du Z, Song J. Hang X, et al. Among authors: du z. Oncol Lett. 2024 Apr 26;27(6):284. doi: 10.3892/ol.2024.14417. eCollection 2024 Jun. Oncol Lett. 2024. PMID: 38736739 Free PMC article.

10

A pseudo-targeted metabolomics for discovery of potential biomarkers of cardiac hypertrophy in rats.

Liu B, Du Z, Zhang W, Guo X, Lu Y, Jiang Y, Tu P. Liu B, et al. Among authors: du z. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Apr 27;1240:124133. doi: 10.1016/j.jchromb.2024.124133. Online ahead of print. J Chromatogr B Analyt Technol Biomed Life Sci. 2024. PMID: 38733887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,834 results

Search Page